Trials / Completed
CompletedNCT02451904
Severe and Cerebral Malaria Investigated Through Host Metabolomics
Microvascular and Metabolic Dysregulation in the Pathogenesis of Severe and Cerebral Malaria Investigated Through Host Metabolomics
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 840 (actual)
- Sponsor
- University of Oxford · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Accepted
Summary
* The aim is to describe disease mechanisms of severe and cerebral malaria and identify new targets for adjunctive therapies. * Despite treatment between 10-30% of patients with severe malaria die. * Metabolic acidosis and cerebral malaria are major complications associated with mortality across all age groups. Still, their underlying pathogenesis remains incompletely understood. * Using a metabolomics approach, this study aims to characterise the spectrum of acids accumulating during acidosis, and investigate patterns of metabolic dysregulation associated with coma and seizures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observation |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2017-09-01
- Completion
- 2017-09-01
- First posted
- 2015-05-22
- Last updated
- 2018-06-20
Locations
1 site across 1 country: Bangladesh
Source: ClinicalTrials.gov record NCT02451904. Inclusion in this directory is not an endorsement.